JPH11513703A - 医薬として用いられる一酸化窒素に基づく組成物 - Google Patents
医薬として用いられる一酸化窒素に基づく組成物Info
- Publication number
- JPH11513703A JPH11513703A JP9516340A JP51634096A JPH11513703A JP H11513703 A JPH11513703 A JP H11513703A JP 9516340 A JP9516340 A JP 9516340A JP 51634096 A JP51634096 A JP 51634096A JP H11513703 A JPH11513703 A JP H11513703A
- Authority
- JP
- Japan
- Prior art keywords
- nitric oxide
- gaseous
- route
- use according
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.血管内経路により虚血を治療または予防することを意図する気体状医薬を 製造するための一酸化窒素(NO)および二酸化炭素(CO2)を含む気体組成 物の使用。 2.血管内経路により塞栓症を治療または予防することを意図する気体状医薬 を製造するための一酸化窒素(NO)および二酸化炭素(CO2)を含む気体組 成物の使用。 3.前記気体状医薬が更に、窒素第一酸化物(nitrogen proto xide)、キセノン、クリプトン、およびそれらの混合物からなる群より選択 される少なくとも1つの気体を含むことを特徴とする請求項1または2のいずれ か1項記載の使用。 4.前記気体状医薬がさらに有効濃度のNOを含むことを特徴とする請求項1 ないし3のいずれか1項記載の使用。 5.前記気体状医薬が1ないし100ppmの濃度のNOを含むことを特徴と する請求項1ないし4のいずれか1項記載の使用。 6.前記気体状医薬が15ないし30ppmの濃度のNOを含むことを特徴と する請求項1ないし5のいずれか1項記載の使用。 7.血管内経路が動脈内経路であることを特徴とする請求項1または2記載の 使用。 8.血管内経路が心臓内経路であることを特徴とする請求項1または2記載の 使用。 9.血管内経路が静脈内経路であることを特徴とする請求項1または2記載の 使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR95/12345 | 1995-10-20 | ||
FR9512345 | 1995-10-20 | ||
PCT/FR1996/001610 WO1997015311A1 (fr) | 1995-10-20 | 1996-10-15 | Composition a base de monoxyde d'azote en tant que medicament |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH11513703A true JPH11513703A (ja) | 1999-11-24 |
Family
ID=9483741
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9516340A Ceased JPH11513703A (ja) | 1995-10-20 | 1996-10-15 | 医薬として用いられる一酸化窒素に基づく組成物 |
JP9516344A Pending JPH11513705A (ja) | 1995-10-20 | 1996-10-17 | 医薬として用いられる一酸化窒素に基づく組成物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9516344A Pending JPH11513705A (ja) | 1995-10-20 | 1996-10-17 | 医薬として用いられる一酸化窒素に基づく組成物 |
Country Status (9)
Country | Link |
---|---|
US (2) | US6051241A (ja) |
EP (2) | EP0855912B1 (ja) |
JP (2) | JPH11513703A (ja) |
AT (1) | ATE209922T1 (ja) |
AU (2) | AU701760B2 (ja) |
CA (1) | CA2188238A1 (ja) |
DE (1) | DE69617719D1 (ja) |
ES (1) | ES2167608T3 (ja) |
WO (2) | WO1997015311A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005533062A (ja) * | 2002-06-12 | 2005-11-04 | メツサー グリースハイム ゲゼルシヤフト ミツト ベシユレンクテル ハフツング | キセノン含有ガスによる脳保護 |
WO2011111581A1 (ja) * | 2010-03-10 | 2011-09-15 | 学校法人北里研究所 | 虚血再灌流障害軽減用治療剤および治療装置 |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6106497A (en) * | 1997-01-31 | 2000-08-22 | Medical Instrument Development Laboratories | System and method for preventing an air embolism in a surgical procedure |
EP0887076A3 (en) * | 1997-05-07 | 1999-03-31 | Saturnus A.G. | Adhesion prevention and an endoscopic insufflation system therefor |
US6660301B1 (en) * | 1998-03-06 | 2003-12-09 | Biosphere Medical, Inc. | Injectable microspheres for dermal augmentation and tissue bulking |
FR2775967B1 (fr) * | 1998-03-10 | 2000-06-23 | Air Liquide | Melange gazeux conditionne supercritique contenant du co2, du no et eventuellement du gaz neutre |
DE19833014A1 (de) * | 1998-07-23 | 2000-01-27 | Messer Griesheim Gmbh | Edelgashaltige Injektionsanästhesiemittel |
US6503740B1 (en) | 2000-02-22 | 2003-01-07 | Biomin, Inc. | Organically modified mineral materials containing engrafted bacteria for chemical contaminant decomposition |
WO2001070289A2 (en) | 2000-03-20 | 2001-09-27 | Biosphere Medical, Inc. | Injectable and swellable microspheres for tissue bulking |
US20040225275A1 (en) * | 2001-08-02 | 2004-11-11 | Reynolds James Dixon | Fetal physiology during maternal surgery or diagnosis |
US6676855B2 (en) * | 2001-08-02 | 2004-01-13 | Duke University | Use of a blood-flow decrease preventing agent in conjunction with insufflating gas |
EP1515731A1 (de) * | 2002-06-12 | 2005-03-23 | Air Liquide Deutschland GmbH | Xenonhaltiges spasmolytikum |
US20050255169A1 (en) * | 2002-07-05 | 2005-11-17 | Messer Griesheim | Adjuvant containing xenon |
DE10336768B4 (de) * | 2002-08-10 | 2010-09-09 | Air Liquide Deutschland Gmbh | Medikament zur Verbesserung der Sauerstoffutilation |
AU2003279823A1 (en) | 2002-10-28 | 2004-05-25 | Northgate Technologies Inc. | Dual-capacity insufflator tube |
US7654975B2 (en) * | 2003-04-24 | 2010-02-02 | Northgate Technologies, Inc. | Mixed-gas insufflation system |
ES2336796T3 (es) * | 2003-10-07 | 2010-04-16 | Northgate Technologies Incorporated | Sistema para suministrar una sustancia a una cavitacion corporal. |
JP5183065B2 (ja) * | 2003-10-31 | 2013-04-17 | トルーデル メディカル インターナショナル | 体腔へ物質を送出するカテーテルを操作するためのシステムと方法 |
CN100475275C (zh) * | 2004-01-05 | 2009-04-08 | 董永华 | 肿瘤血管栓塞剂及其储存和释放装置 |
SE0402221D0 (sv) | 2004-09-14 | 2004-09-14 | Aerocrine Ab | Treatment of insufficient perfusion |
US9358193B2 (en) * | 2005-02-15 | 2016-06-07 | Martin S. Giniger | Whitening compositions and methods involving nitrogen oxide radicals |
CA3099231A1 (en) | 2006-08-04 | 2008-02-07 | Northgate Technologies Inc. | In-dwelling port for access into a body |
US11129911B2 (en) | 2011-05-05 | 2021-09-28 | Cedars-Sinai Medical Center | Assessment of coronary heart disease with carbon dioxide |
EP2704577A4 (en) * | 2011-05-05 | 2014-10-15 | Cedars Sinai Medical Center | EVALUATION OF A CORONARY HEART DISEASE WITH CARBON DIOXIDE |
CN103565745A (zh) | 2012-08-10 | 2014-02-12 | 德克萨斯州大学系统董事会 | 用于治疗中风的神经保护性脂质体组合物和方法 |
CN105228591B (zh) | 2013-03-15 | 2019-08-13 | 德克萨斯州大学系统董事会 | 富含稀有气体的液体及其制备和使用方法 |
US9522247B2 (en) | 2013-06-28 | 2016-12-20 | L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude | Method of treating a patient having pulmonary hypertension by long term NO therapy |
US9566407B2 (en) | 2013-06-28 | 2017-02-14 | L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude | Nasal cannula assembly with flow control passage communicating with a deformable reservoir |
US9486600B2 (en) | 2013-06-28 | 2016-11-08 | L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude | Nasal cannula assembly with inhalation valves communicating with a deformable reservoir |
US9517318B2 (en) | 2013-06-28 | 2016-12-13 | L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude | Method of delivering medical gases via a nasal cannula assembly with flow control passage communicating with a deformable reservoir |
US9522248B2 (en) | 2013-06-28 | 2016-12-20 | L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude | Breathing assistance apparatus for delivery of nitric oxide to a patient by means of a nasal cannula assembly with flow control passage |
US9492626B2 (en) | 2013-06-28 | 2016-11-15 | L'Air Liquide, Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude | Breathing assistance assemblies suitable for long term no therapy |
WO2015021078A1 (en) | 2013-08-05 | 2015-02-12 | Cedars-Sinai Medical Center | Methods for reducing ischemia-reperfusion injury |
US9572595B1 (en) | 2014-03-05 | 2017-02-21 | Northgate Technologies Inc. | In-dwelling port for access into a body |
GB2579240B (en) | 2018-11-27 | 2020-12-16 | Attgeno Ab | New processes, compositions and medical uses |
GB202007929D0 (en) | 2020-05-27 | 2020-07-08 | Attgeno Ab | New medical uses |
CN111840583B (zh) * | 2020-08-06 | 2023-03-28 | 温州医科大学 | 血管内皮损伤治疗的药物制剂 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5443826A (en) * | 1988-08-02 | 1995-08-22 | Borody; Thomas J. | Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli |
DE69127756T2 (de) * | 1990-12-05 | 1998-02-05 | Gen Hospital Corp | Verwendung von no zur behandlung oder prävention der bronchokonstriktion |
US5536241A (en) * | 1990-12-05 | 1996-07-16 | The General Hospital Corporation | Methods and devices for relaxing smooth muscle contractions |
US5427797A (en) * | 1993-04-06 | 1995-06-27 | Brigham And Women's Hospital | Systemic effects of nitric oxide inhalation |
-
1996
- 1996-10-15 AU AU73051/96A patent/AU701760B2/en not_active Ceased
- 1996-10-15 EP EP96934916A patent/EP0855912B1/fr not_active Expired - Lifetime
- 1996-10-15 WO PCT/FR1996/001610 patent/WO1997015311A1/fr active IP Right Grant
- 1996-10-15 ES ES96934916T patent/ES2167608T3/es not_active Expired - Lifetime
- 1996-10-15 JP JP9516340A patent/JPH11513703A/ja not_active Ceased
- 1996-10-15 DE DE69617719T patent/DE69617719D1/de not_active Expired - Lifetime
- 1996-10-15 AT AT96934916T patent/ATE209922T1/de not_active IP Right Cessation
- 1996-10-17 AU AU73058/96A patent/AU7305896A/en not_active Abandoned
- 1996-10-17 US US09/051,641 patent/US6051241A/en not_active Expired - Fee Related
- 1996-10-17 JP JP9516344A patent/JPH11513705A/ja active Pending
- 1996-10-17 WO PCT/FR1996/001624 patent/WO1997015312A1/fr not_active Application Discontinuation
- 1996-10-17 EP EP96934928A patent/EP0859620A1/fr not_active Ceased
- 1996-10-18 CA CA002188238A patent/CA2188238A1/fr not_active Abandoned
- 1996-10-18 US US08/733,919 patent/US5670177A/en not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005533062A (ja) * | 2002-06-12 | 2005-11-04 | メツサー グリースハイム ゲゼルシヤフト ミツト ベシユレンクテル ハフツング | キセノン含有ガスによる脳保護 |
WO2011111581A1 (ja) * | 2010-03-10 | 2011-09-15 | 学校法人北里研究所 | 虚血再灌流障害軽減用治療剤および治療装置 |
US9101556B2 (en) | 2010-03-10 | 2015-08-11 | The Kitasato Institute | Therapeutic agent and therapeutic device for alleviating ischemia-reperfusion injury |
Also Published As
Publication number | Publication date |
---|---|
AU701760B2 (en) | 1999-02-04 |
US5670177A (en) | 1997-09-23 |
AU7305896A (en) | 1997-05-15 |
EP0855912B1 (fr) | 2001-12-05 |
DE69617719D1 (de) | 2002-01-17 |
JPH11513705A (ja) | 1999-11-24 |
ES2167608T3 (es) | 2002-05-16 |
EP0859620A1 (fr) | 1998-08-26 |
ATE209922T1 (de) | 2001-12-15 |
EP0855912A1 (fr) | 1998-08-05 |
AU7305196A (en) | 1997-05-15 |
WO1997015311A1 (fr) | 1997-05-01 |
US6051241A (en) | 2000-04-18 |
CA2188238A1 (fr) | 1997-04-21 |
WO1997015312A1 (fr) | 1997-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH11513703A (ja) | 医薬として用いられる一酸化窒素に基づく組成物 | |
US6314956B1 (en) | Pulmonary delivery of NO group-containing compound in gas form to treat respiratory, cardiac and blood disorders | |
US6599878B2 (en) | Superoxygenating blood substitutes based on hemoglobin and dihydropyidine compositions | |
Stamler et al. | Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. | |
US20170281673A1 (en) | Use of nitrite salts for the treatment of cardiovascular conditions | |
US6063407A (en) | Treatment of vascular thrombosis and restenosis with inhaled nitric oxide | |
JPH10507443A (ja) | 一酸化窒素の合成を刺激する方法及び製剤 | |
JPH09500366A (ja) | 固形腫瘍及び他の疾患の治療のための薬剤の治療効果を改良する方法 | |
US20050255178A1 (en) | Enhancing the effectiveness of an inhaled therapeutic gas | |
JP4890266B2 (ja) | D−リボースを含む、麻酔からの回復のための医薬 | |
Mathes et al. | Continuous spinal anesthetic technique for endovascular aortic stent graft surgery | |
Pearson et al. | Augmented endothelium‐dependent constriction to hypoxia early and late following reperfusion of the canine coronary artery | |
McKenzie et al. | Effects of diaspirin crosslinked haemoglobin during coronary angioplasty in the swine | |
KR20060128972A (ko) | 적혈구 기능 수식 물질 | |
Briend et al. | Injectable NO/CO 2 gaseous mixture | |
JP2003526668A (ja) | 心臓血管損傷の調節 | |
Szwajkun et al. | Role of endothelium-derived relaxing factor and prostaglandins in responses of coronary arteries to thromboxane in vivo. | |
Steven et al. | Anesthesia for congenital heart surgery | |
Fang-qi et al. | Effect of nebulized nitroglycerin on children with ventricular septal defect and pulmonary hypertension | |
Bratel et al. | Ventilation/perfusion ratios in pulmonary arterial hypertension: effects of IV and inhaled prostacyclin derivatives | |
Gulielmos | Beating Heart Bypass Surgery and Minimally Invasive Conduit Harvesting | |
Tarhan | Anesthesia for patients with Ischemic Heart Disease | |
UA46559A (uk) | Спосіб нормоволемічної гемодилюції |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20061003 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20061221 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20070219 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070403 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070703 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20071002 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20071112 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20071031 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20071210 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20080214 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080325 |